SemBioSys Products and Technology

Our plant technology can be applied to a wide variety of product opportunities - including pharmaceutical and non-pharmaceutical.

Due to the inherent scalability and economic advantages of plants compared to existing production methods, our technology enables the production of pharmaceuticals otherwise constrained by cost and capacity barriers. In this way, our technology can provide global access to life-saving therapies.

Our current pharmaceutical product candidates include insulin for diabetes and Apo AI_Milano for cardiovascular disease.

The same advantages that drive our pharmaceutical opportunities also apply to our non-pharmaceutical products, which include topical ingredients that are delivering innovation and value for personal care producers, nutritional oils (omega fatty acids) for use in a variety of consumer goods, such as functional foods, and applications for agricultural biotechnology.

Our initial personal care products, that are now sold by our former spin-out company, Botaneco, are already on the market and performing well. It demonstrated the viability and strength of our technology for the production of consumer goods.

As we continue to partner our pharmaceutical products, we will work towards identifying new pipeline products, such as functional food ingredients.